Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Breast Cancer Kit - BRCAaccuTest™

Total solution for genetic breast cancer BRCA genetic test(CE-IVD)

Clinically validated next generation sequencing (NGS) panel and data analysis software for rapid and reliable detection of BRCA 1/2 mutations

BRCAaccuTestTM is a next generation sequencing (NGS)-based in vitro diagnostic (IVD) product which detects mutations in BRCA1 /BRCA2 genes. BRCAaccuTestTM consists of NGS panel for detecting variants and clinical data analysis software (S/W). Rapid and precise detection of various mutations in BRCA 1/2 with NGS can be accomplished and the user-oriented analysis software enables convenient generation of clinical report.


  • Detection of mutations in the whole exon region coding for BRCA1 and BRCA2 gene proteins
  • Experiment and decryption completed in 2 days
  • Using DNA extracted from blood
  • PCR amplicon-based library production
  • Provide data QC, analysis and automated variant information by using optimized analysis software for BRCA1 and 2 panels
  • Production and management from GMP and ISO 13485 certified organizations
  • CE-IVD / KFDA Class III